Skip to search formSkip to main contentSkip to account menu

BMS201038

Known as: BMS 201038, BMS-201038 
National Institutes of Health

Related topics

Related topics

5 relations
AEGR 733

Broader (2)

Benzimidazoleslomitapide mesylate

Narrower (2)

Juxtapidlomitapide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Inhibition of microsomal triglyceride transfer protein improves insulin sensitivity and reduces atherogenic risk in Zucker fatty rats
1. Insulin‐resistant states are commonly associated with a significantly higher risk of atherosclerosis. Insulin resistance has… 
Highly Cited
2007
Highly Cited
2007
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.
BACKGROUND Patients with homozygous familial hypercholesterolemia have markedly elevated cholesterol levels, which respond poorly… 
2002
2002
Atorvastatin increases hepatic fatty acid beta-oxidation in sucrose-fed rats: comparison with an MTP inhibitor.
2001
2001
Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells.
Highly Cited
2001
Highly Cited
2001
A novel series of highly potent benzimidazole-based microsomal triglyceride transfer protein inhibitors.
A series of benzimidazole-based analogues of the potent MTP inhibitor BMS-201038 were discovered. Incorporation of an… 
2000
2000
A revolution in drug discovery
Several new drugs now in phase II clinical trials have got there at speed. Gone are the days of laboriously slow organic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License